Home
ONCY
ONCY News

Latest Oncolytics Biotech Inc. (ONCY) News on July 27, 2024

Here's Why We're Watching Oncolytics Biotech's (TSE:ONC) Cash Burn Situation

Simply Wall St.

2 days ago

Here's Why We're Watching Oncolytics Biotech's (TSE:ONC) Cash Burn Situation

Oncolytics Biotech® to Host Conference Call to Discuss Second Quarter Financial Results and Recent Operational Highlights

CNW Group

3 days ago

Oncolytics Biotech® to Host Conference Call to Discuss Second Quarter Financial Results and Recent Operational Highlights

MT Newswires

a month ago

Oncolytics Biotech UP 1.9% In US Premarket Announces "Productive" FDA Type C Meeting on Metastatic Breast Cancer Program

Oncolytics Biotech® Announces Productive FDA Type C Meeting on its Metastatic Breast Cancer Program

CNW Group

a month ago

Oncolytics Biotech® Announces Productive FDA Type C Meeting on its Metastatic Breast Cancer Program

MT Newswires

a month ago

Oncolytics Biotech CEO Matt Coffey to Take Medical Leave of Absence

MT Newswires

a month ago

Oncolytics Biotech President and CEO Coffey to Take Medical Leave of Absence

Oncolytics Biotech® Announces President and Chief Executive Officer Dr. Matt Coffey to Take Medical Leave of Absence

PR Newswire

a month ago

Oncolytics Biotech® Announces President and Chief Executive Officer Dr. Matt Coffey to Take Medical Leave of Absence

Oncolytics doses first subject in pancreatic cancer trial

Clinical Trials Arena

a month ago

Oncolytics doses first subject in pancreatic cancer trial

MT Newswires

a month ago

Oncolytics Biotech Doses First Patient in Pelareorep Study Involving Modified FOLFIRINOX

Oncolytics Biotech® Doses First Patient in Study of Pelareorep/FOLFIRINOX Combination Therapy in Pancreatic Cancer

PR Newswire

a month ago

Oncolytics Biotech® Doses First Patient in Study of Pelareorep/FOLFIRINOX Combination Therapy in Pancreatic Cancer

Oncolytics Biotech (ONCY) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now

Zacks

2 months ago

Oncolytics Biotech (ONCY) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now

MT Newswires

2 months ago

Oncolytics Biotech Says ASCO Abstracts Highlight Pelareorep's Treatment Potential in Pancreatic Cancer

Oncolytics Biotech® ASCO Abstracts Highlight Pelareorep's Potential in Pancreatic Cancer and Immunotherapeutic Mechanism of Action

CNW Group

2 months ago

Oncolytics Biotech® ASCO Abstracts Highlight Pelareorep's Potential in Pancreatic Cancer and Immunotherapeutic Mechanism of Action

Oncolytics Biotech® Announces Voting Results from the Annual General Meeting of Shareholders

PR Newswire

2 months ago

Oncolytics Biotech® Announces Voting Results from the Annual General Meeting of Shareholders

MT Newswires

2 months ago

Oncolytics Biotech Announces Preliminary Collaboration with GCAR for Inclusion of Pelareorep in Pancreatic Cancer Trial

Oncolytics Biotech® Announces Preliminary Collaboration with GCAR for Inclusion of Pelareorep in Anticipated Pancreatic Cancer Trial

CNW Group

2 months ago

Oncolytics Biotech® Announces Preliminary Collaboration with GCAR for Inclusion of Pelareorep in Anticipated Pancreatic Cancer Trial

Oncolytics Biotech Inc. (NASDAQ:ONCY) Q1 2024 Earnings Call Transcript

Insider Monkey

3 months ago

Oncolytics Biotech Inc. (NASDAQ:ONCY) Q1 2024 Earnings Call Transcript

MT Newswires

3 months ago

Oncolytics Biotech Reports a First-Quarter Loss of Near $7 Million

Oncolytics Biotech® Reports First Quarter 2024 Financial Results and Operational Highlights

PR Newswire

3 months ago

Oncolytics Biotech® Reports First Quarter 2024 Financial Results and Operational Highlights

MT Newswires

3 months ago

Oncolytics Biotech Receives German Regulatory Clearance to Evaluate Pelareorep with Modified Folfirinox in Pancreatic Cancer

Oncolytics Biotech® Receives Regulatory Clearance to Evaluate Pelareorep in Combination with Modified FOLFIRINOX +/- an anti-PD-L1 Inhibitor in Pancreatic Cancer

PR Newswire

3 months ago

Oncolytics Biotech® Receives Regulatory Clearance to Evaluate Pelareorep in Combination with Modified FOLFIRINOX +/- an anti-PD-L1 Inhibitor in Pancreatic Cancer

Oncolytics Biotech® Receives Regulatory Clearance to Evaluate Pelareorep in Combination with Modified FOLFIRINOX +/- an anti-PD-L1 Inhibitor in Pancreatic Cancer

CNW Group

3 months ago

Oncolytics Biotech® Receives Regulatory Clearance to Evaluate Pelareorep in Combination with Modified FOLFIRINOX +/- an anti-PD-L1 Inhibitor in Pancreatic Cancer

Oncolytics Biotech® to Participate in a Fireside Chat at the 2024 RBC Capital Markets Global Healthcare Conference

PR Newswire

3 months ago

Oncolytics Biotech® to Participate in a Fireside Chat at the 2024 RBC Capital Markets Global Healthcare Conference

Oncolytics Biotech® to Participate in a Fireside Chat at the 2024 RBC Capital Markets Global Healthcare Conference

CNW Group

3 months ago

Oncolytics Biotech® to Participate in a Fireside Chat at the 2024 RBC Capital Markets Global Healthcare Conference

Oncolytics Biotech® to Host Conference Call to Discuss First Quarter Financial Results and Recent Operational Highlights

CNW Group

3 months ago

Oncolytics Biotech® to Host Conference Call to Discuss First Quarter Financial Results and Recent Operational Highlights

Oncolytics Biotech® to Host Conference Call to Discuss First Quarter Financial Results and Recent Operational Highlights

PR Newswire

3 months ago

Oncolytics Biotech® to Host Conference Call to Discuss First Quarter Financial Results and Recent Operational Highlights

Oncolytics Biotech® Announces Upcoming Presentations at the American Society of Clinical Oncology Annual Meeting

PR Newswire

3 months ago

Oncolytics Biotech® Announces Upcoming Presentations at the American Society of Clinical Oncology Annual Meeting

Oncolytics Biotech® Advances Toward Registration-Enabling Trial for Pelareorep in Breast Cancer with Submission of Type C Meeting Request to FDA

PR Newswire

4 months ago

Oncolytics Biotech® Advances Toward Registration-Enabling Trial for Pelareorep in Breast Cancer with Submission of Type C Meeting Request to FDA

Oncolytics Biotech® Advances Toward Registration-Enabling Trial for Pelareorep in Breast Cancer with Submission of Type C Meeting Request to FDA

CNW Group

4 months ago

Oncolytics Biotech® Advances Toward Registration-Enabling Trial for Pelareorep in Breast Cancer with Submission of Type C Meeting Request to FDA

Oncolytics Biotech® to Participate in a Panel Presentation at Canaccord Genuity's Horizons in Oncology Virtual Conference

CNW Group

4 months ago

Oncolytics Biotech® to Participate in a Panel Presentation at Canaccord Genuity's Horizons in Oncology Virtual Conference

Oncolytics Biotech Inc. (NASDAQ:ONCY) Q4 2023 Earnings Call Transcript

Insider Monkey

5 months ago

Oncolytics Biotech Inc. (NASDAQ:ONCY) Q4 2023 Earnings Call Transcript

Oncolytics Biotech® Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights

CNW Group

5 months ago

Oncolytics Biotech® Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights

Biotech/Oncology Stocks Targeting the Pancreatic Cancer Market - A Race Worth Winning

Newsfile

5 months ago

Biotech/Oncology Stocks Targeting the Pancreatic Cancer Market - A Race Worth Winning

Oncolytics Biotech® Files Amendment to Initiate New Pancreatic Cancer GOBLET Cohort Supported by PanCAN

CNW Group

5 months ago

Oncolytics Biotech® Files Amendment to Initiate New Pancreatic Cancer GOBLET Cohort Supported by PanCAN

Oncolytics Biotech® to Host Conference Call to Discuss Fourth Quarter and Full Year Financial Results and Recent Operational Highlights

CNW Group

5 months ago

Oncolytics Biotech® to Host Conference Call to Discuss Fourth Quarter and Full Year Financial Results and Recent Operational Highlights

Oncolytics Biotech® Announces Presentation at the Cancer Advocacy Group of Louisiana's 3rd Annual NeauxCancer Conference

CNW Group

5 months ago

Oncolytics Biotech® Announces Presentation at the Cancer Advocacy Group of Louisiana's 3rd Annual NeauxCancer Conference

Oncolytics Biotech® Announces Presentation at the Cancer Advocacy Group of Louisiana's 3rd Annual NeauxCancer Conference

PR Newswire

5 months ago

Oncolytics Biotech® Announces Presentation at the Cancer Advocacy Group of Louisiana's 3rd Annual NeauxCancer Conference

Here's Why We're Watching Oncolytics Biotech's (TSE:ONC) Cash Burn Situation

Simply Wall St.

5 months ago

Here's Why We're Watching Oncolytics Biotech's (TSE:ONC) Cash Burn Situation

Cancer Immunotherapy Stocks - Tapping into Immune Systems for Next Generation Treatments

Newsfile

5 months ago

Cancer Immunotherapy Stocks - Tapping into Immune Systems for Next Generation Treatments

Oncolytics Biotech® Initiates Enrollment Expansion of GOBLET Anal Cancer Cohort

CNW Group

5 months ago

Oncolytics Biotech® Initiates Enrollment Expansion of GOBLET Anal Cancer Cohort

P3 Health Partners to Participate in The 2024 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

Business Wire

6 months ago

P3 Health Partners to Participate in The 2024 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

ISG to Publish Reports on Google Cloud Ecosystem

Business Wire

6 months ago

ISG to Publish Reports on Google Cloud Ecosystem

Community West Bancshares Reports Full Year Earnings Amid Merger Developments

GuruFocus.com

6 months ago

Community West Bancshares Reports Full Year Earnings Amid Merger Developments

3 Penny Stocks to Turn $999 Into $1 Million: January 2024

InvestorPlace

6 months ago

3 Penny Stocks to Turn $999 Into $1 Million: January 2024

Here's Why DHI Group (NYSE:DHX) Has Caught The Eye Of Investors

Simply Wall St.

6 months ago

Here's Why DHI Group (NYSE:DHX) Has Caught The Eye Of Investors

BCB Bancorp, Inc. (NASDAQ:BCBP) most popular amongst retail investors who own 51% of the shares, institutions hold 36%

Simply Wall St.

6 months ago

BCB Bancorp, Inc. (NASDAQ:BCBP) most popular amongst retail investors who own 51% of the shares, institutions hold 36%

GuruFocus.com

6 months ago

BCB Bancorp Inc (BCBP) Reports Decline in Q4 Earnings and Announces Dividend

Compared to Estimates, BCB Bancorp (BCBP) Q4 Earnings: A Look at Key Metrics

Zacks

6 months ago

Compared to Estimates, BCB Bancorp (BCBP) Q4 Earnings: A Look at Key Metrics

Strength Seen in Flux Power Holdings, Inc. (FLUX): Can Its 8.4% Jump Turn into More Strength?

Zacks

6 months ago

Strength Seen in Flux Power Holdings, Inc. (FLUX): Can Its 8.4% Jump Turn into More Strength?

Provident Financial Holdings To Host Earnings Release Conference Call

GlobeNewswire

6 months ago

Provident Financial Holdings To Host Earnings Release Conference Call

Hyliion to Participate in POWERGEN International Conference

Business Wire

6 months ago

Hyliion to Participate in POWERGEN International Conference

Sidoti Events, LLC's Virtual January Micro-Cap Conference

ACCESSWIRE

6 months ago

Sidoti Events, LLC's Virtual January Micro-Cap Conference

TAT Technologies signs another 5-year contract with an international air carrier for APU MRO services with estimated total revenues of $10 million

PR Newswire

6 months ago

TAT Technologies signs another 5-year contract with an international air carrier for APU MRO services with estimated total revenues of $10 million

China Automotive Systems (NASDAQ:CAAS) Is Doing The Right Things To Multiply Its Share Price

Simply Wall St.

6 months ago

China Automotive Systems (NASDAQ:CAAS) Is Doing The Right Things To Multiply Its Share Price

C&F Financial (NASDAQ:CFFI) shareholders have earned a 19% CAGR over the last three years

Simply Wall St.

6 months ago

C&F Financial (NASDAQ:CFFI) shareholders have earned a 19% CAGR over the last three years

Anixa Biosciences to Present at Sidoti Micro-Cap Virtual Conference on January 17, 2024

PR Newswire

7 months ago

Anixa Biosciences to Present at Sidoti Micro-Cap Virtual Conference on January 17, 2024

Oncolytics Biotech® Appoints Patricia S. Andrews to its Board of Directors

CNW Group

7 months ago

Oncolytics Biotech® Appoints Patricia S. Andrews to its Board of Directors

Oncolytics Biotech® Appoints Patricia S. Andrews to its Board of Directors

PR Newswire

7 months ago

Oncolytics Biotech® Appoints Patricia S. Andrews to its Board of Directors

Business Wire

7 months ago

Tilly’s, Inc. Announces 2023 Holiday Period Net Sales, Updates Fourth Quarter Outlook

Argo Blockchain PLC Announces £7.8 million ($9.9 million) Placing

ACCESSWIRE

7 months ago

Argo Blockchain PLC Announces £7.8 million ($9.9 million) Placing

ProQR and Rett Syndrome Research Trust Join Forces with Axiomer™ RNA Editing Collaboration

GlobeNewswire

7 months ago

ProQR and Rett Syndrome Research Trust Join Forces with Axiomer™ RNA Editing Collaboration

Oncolytics Biotech® Recaps 2023 Accomplishments, Provides Outlook for 2024

CNW Group

7 months ago

Oncolytics Biotech® Recaps 2023 Accomplishments, Provides Outlook for 2024

Xeris Biopharma Updates Its Outlook for 2023

Business Wire

7 months ago

Xeris Biopharma Updates Its Outlook for 2023

Oncolytics Biotech® Recaps 2023 Accomplishments, Provides Outlook for 2024

PR Newswire

7 months ago

Oncolytics Biotech® Recaps 2023 Accomplishments, Provides Outlook for 2024

RETRANSMISSION: HIVE Digital Increases HODL Position and Provides December 2023 Production and Corporate Update

Newsfile

7 months ago

RETRANSMISSION: HIVE Digital Increases HODL Position and Provides December 2023 Production and Corporate Update

HIVE Digital Increases HODL Position and Provides December 2023 Production and Corporate Update

Newsfile

7 months ago

HIVE Digital Increases HODL Position and Provides December 2023 Production and Corporate Update

Resources Connection Inc (RGP) Faces Revenue Decline Amid Economic Challenges in Q2 Fiscal 2024

GuruFocus.com

7 months ago

Resources Connection Inc (RGP) Faces Revenue Decline Amid Economic Challenges in Q2 Fiscal 2024

Geospace Technologies Sells $30M in Ocean Bottom Nodes

Business Wire

7 months ago

Geospace Technologies Sells $30M in Ocean Bottom Nodes

Emeren Group Releases 2022 Environmental, Social and Governance Report

PR Newswire

7 months ago

Emeren Group Releases 2022 Environmental, Social and Governance Report

3 Quantum Computing Stocks You’ll Regret Not Buying Soon

InvestorPlace

7 months ago

3 Quantum Computing Stocks You’ll Regret Not Buying Soon

Smith-Midland Appoints New Members to its Board of Directors

ACCESSWIRE

7 months ago

Smith-Midland Appoints New Members to its Board of Directors

Business Wire

7 months ago

Tilly’s, Inc. Announces Participation in ICR Conference 2024

L.B. Foster Company Announces the Expansion of its Board of Directors and Election of David J. Meyer

GlobeNewswire

7 months ago

L.B. Foster Company Announces the Expansion of its Board of Directors and Election of David J. Meyer

Despite Fast-paced Momentum, Willdan (WLDN) Is Still a Bargain Stock

Zacks

7 months ago

Despite Fast-paced Momentum, Willdan (WLDN) Is Still a Bargain Stock

12 Extreme Dividend Stocks With Upside Potential

Insider Monkey

7 months ago

12 Extreme Dividend Stocks With Upside Potential

AFC Gamma Announces Fourth Quarter 2023 Dividend

GlobeNewswire

7 months ago

AFC Gamma Announces Fourth Quarter 2023 Dividend

Marketing Dive

7 months ago

Trivago introduces brand refresh with ads localized with help from AI

Zacks Industry Outlook Highlights HCA Healthcare, Universal Health Services, Tenet Healthcare, Acadia Healthcare Company and Community Health Systems

Zacks

7 months ago

Zacks Industry Outlook Highlights HCA Healthcare, Universal Health Services, Tenet Healthcare, Acadia Healthcare Company and Community Health Systems

SCALINX and Arteris Partner on Advanced Communications Innovation

GlobeNewswire

7 months ago

SCALINX and Arteris Partner on Advanced Communications Innovation

When To Sell Growth Stocks: Why This Rule Worked Like Magic For This Small-Cap Leader

Investor's Business Daily

7 months ago

When To Sell Growth Stocks: Why This Rule Worked Like Magic For This Small-Cap Leader

Comtech Telecommunications Corp. (NASDAQ:CMTL) Q1 2024 Earnings Call Transcript

Insider Monkey

8 months ago

Comtech Telecommunications Corp. (NASDAQ:CMTL) Q1 2024 Earnings Call Transcript

Epsilon Energy (NASDAQ:EPSN) Is Paying Out A Dividend Of $0.0625

Simply Wall St.

8 months ago

Epsilon Energy (NASDAQ:EPSN) Is Paying Out A Dividend Of $0.0625

Oncolytics Biotech® and SOLTI Present Positive Translational Data at SABCS

CNW Group

8 months ago

Oncolytics Biotech® and SOLTI Present Positive Translational Data at SABCS

Oncolytics Biotech® and SOLTI Present Positive Translational Data at SABCS

PR Newswire

8 months ago

Oncolytics Biotech® and SOLTI Present Positive Translational Data at SABCS

Vera Bradley (VRA) Beats Q3 Earnings Estimates

Zacks

8 months ago

Vera Bradley (VRA) Beats Q3 Earnings Estimates

Associated Press Finance

8 months ago

Vera Bradley: Fiscal Q3 Earnings Snapshot

Vera Bradley Announces Third Quarter Fiscal Year 2024 Results

GlobeNewswire

8 months ago

Vera Bradley Announces Third Quarter Fiscal Year 2024 Results

Citi (C) Partners With Traydstream to Automate Document Services

Zacks

8 months ago

Citi (C) Partners With Traydstream to Automate Document Services

Sidoti Events, LLC's Virtual December Small-Cap Conference

ACCESSWIRE

8 months ago

Sidoti Events, LLC's Virtual December Small-Cap Conference

Spire Global Awarded Space Services Contract by Lacuna Space to Build and Operate Six Satellites for a Dedicated IoT Constellation

Business Wire

8 months ago

Spire Global Awarded Space Services Contract by Lacuna Space to Build and Operate Six Satellites for a Dedicated IoT Constellation

Weak Financial Prospects Seem To Be Dragging Down The Marcus Corporation (NYSE:MCS) Stock

Simply Wall St.

8 months ago

Weak Financial Prospects Seem To Be Dragging Down The Marcus Corporation (NYSE:MCS) Stock

Global Water Resources (GWRS) Board Allows 1% Dividend Hike

Zacks

8 months ago

Global Water Resources (GWRS) Board Allows 1% Dividend Hike

Vor Bio to Participate in the JMP Securities Hematology and Oncology Summit

GlobeNewswire

8 months ago

Vor Bio to Participate in the JMP Securities Hematology and Oncology Summit

COO & Executive VP of American Vanguard Picks Up 6.4% More Stock

Simply Wall St.

8 months ago

COO & Executive VP of American Vanguard Picks Up 6.4% More Stock

Zapata AI Welcomes Jon Zorio as Chief Revenue Officer

Business Wire

8 months ago

Zapata AI Welcomes Jon Zorio as Chief Revenue Officer

Chief Technology Officer of Root Picks Up 12% More Stock

Simply Wall St.

8 months ago

Chief Technology Officer of Root Picks Up 12% More Stock

ArrowMark Financial Corp. Releases Month End Estimated Net Asset Value as of October 2023

GlobeNewswire

8 months ago

ArrowMark Financial Corp. Releases Month End Estimated Net Asset Value as of October 2023

OFS Credit Company Provides October 2023 Net Asset Value Update

Business Wire

8 months ago

OFS Credit Company Provides October 2023 Net Asset Value Update

VIZSLA SILVER IS HONORED TO WELCOME MINING HALL OF FAME MEMBER EDUARDO LUNA TO ITS BOARD OF DIRECTORS

CNW Group

8 months ago

VIZSLA SILVER IS HONORED TO WELCOME MINING HALL OF FAME MEMBER EDUARDO LUNA TO ITS BOARD OF DIRECTORS

Telesat Selects Aalyria’s Spacetime for Orchestration of Its Revolutionary Telesat Lightspeed Constellation

GlobeNewswire

8 months ago

Telesat Selects Aalyria’s Spacetime for Orchestration of Its Revolutionary Telesat Lightspeed Constellation

Share on Social Networks: